F. Fianchi
Agostino Gemelli University Polyclinic
11 Papers
F. Fianchi is an academic researcher from Agostino Gemelli University Polyclinic. The author has contributed to research in topics: Gut flora & Medicine. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia.
Francesca Romana Ponziani,Anna Picca,Anna Picca,Emanuele Marzetti,Riccardo Calvani,Riccardo Calvani,Giorgia Conta,Federica Del Chierico,Giorgio Capuani,Giorgio Capuani,Mariella Faccia,F. Fianchi,Barbara Funaro,Hélio José Coelho-Júnior,Valentina Petito,Emanuele Rinninella,Francesco Paroni Sterbini,Sofia Reddel,Pamela Vernocchi,Maria Cristina Mele,Alfredo Miccheli,Lorenza Putignani,Maurizio Sanguinetti,Maurizio Pompili,Antonio Gasbarrini +24 more
TL;DR: The role of the gut-liver-muscle axis in this setting has been poorly investigated in this article, where the authors identify gut microbiota, metabolic, and inflammatory signatures associated with sarcopenia in cirrhotic patients.
67
Gut microbiota in primary sclerosing cholangitis: from prognostic role to therapeutic implications.
Valeria Maccauro,F. Fianchi,Antonio Gasbarrini,Francesca Romana Ponziani +3 more
TL;DR: The gut microbiota plays a crucial role in the pathogenesis and progression of primary sclerosing cholangitis, influencing bile acid metabolism, inflammation and immune response. Targeting the gut microbiota offers a novel therapeutic avenue for PSC.
2
T.03.10 high rate of late referral and diagnosis of liver cirrhosis during a four-year period in a second level medical center: the experience of fondazione policlinico gemelli
Maria Grazia Massaro,T. Galasso,A. Lo Monaco,Richard A Maresca,Valentina Ruggieri,Amanda Martins Severino,Francesco Santopaolo,F. Fianchi,Adriano Gasbarrini,Francesca Romana Ponziani,Mario Pompili +10 more
Evolution of focal nodular hyperplasia during long-term ultrasound follow-up: results from a single-center study
Mattia Paratore,Matteo Garcovich,Annamaria Amodeo,F. Fianchi,Francesco Santopaolo,Francesca Romana Ponziani,Maria Assunta Zocco,A. Gasbarrini,Laura Riccardi,Maurizio Pompili +9 more
TL;DR: A single-center study of 55 patients with 94 focal nodular hyperplasia (FNH) lesions found most (83%) remained stable or decreased in size over 58.3-month follow-up, with no association between size changes and clinical factors.
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune liver disease
Lorenz Kocheise,Ignazio Piseddu,Joscha Vonderlin,Eric T.T.L. Tjwa,Gustav Buescher,Lucy,Meunier,F. Fianchi,Jérôme Dumortier,Mar Riveiro-Barciela,Tom J. G. Gevers,Benedetta Terziroli Beretta-Piccoli,María-Carlota Londoño,Thomas G. Roesner,Vincent Joerg,Constantin Schmidt,F Glaser,P. Jan,Sutter,T Fründt,Ansgar W. Lohse,Samuel Huber,Johann von Felden,Marcial,Kornelius Schulze +24 more
TL;DR: In this paper , the safety profile of ICI for the treatment of malignancies in patients diagnosed with autoimmune liver disease (AILD) remains unclear, and due to this uncertainty, these patients were excluded from ICI clinical trials and ICI are withheld from this patient group.